Minireviews
Copyright ©The Author(s) 2019.
World J Diabetes. Aug 15, 2019; 10(8): 446-453
Published online Aug 15, 2019. doi: 10.4239/wjd.v10.i8.446
Table 2 Cardiovascular effect of glucagon like peptide-1 receptor agonists
Anti-atherosclerotic effectDecrease matrix metalloproteinase 2; decrease vascular smooth muscle cell proliferation
Improves endothelial functionIncrease nitric oxide-induced vasodilation; decrease oxidative stress
Anti-inflammatory effectSuppress human macrophagesby inhibition of protein kinase C
Decrease infarct/injury sizeDecrease glucose-induced apoptosis; decrease intracellular calcium overload
Modifies risk factorsImprove glycemic control; decrease body weight; decrease blood pressure; decrease low-density lipoprotein